Voya Investment Management LLC Has $5.43 Million Stock Holdings in STERIS plc $STE

Voya Investment Management LLC lowered its holdings in shares of STERIS plc (NYSE:STE) by 22.5% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 21,956 shares of the medical equipment provider’s stock after selling 6,358 shares during the period. Voya Investment Management LLC’s holdings in STERIS were worth $5,433,000 at the end of the most recent quarter.

A number of other hedge funds have also added to or reduced their stakes in the business. Orbis Allan Gray Ltd acquired a new stake in shares of STERIS during the 1st quarter worth approximately $349,950,000. Norges Bank acquired a new position in shares of STERIS during the 2nd quarter valued at $289,132,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its stake in STERIS by 55.2% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,520,479 shares of the medical equipment provider’s stock worth $344,617,000 after acquiring an additional 540,999 shares in the last quarter. Invesco Ltd. grew its holdings in STERIS by 32.2% in the second quarter. Invesco Ltd. now owns 1,220,699 shares of the medical equipment provider’s stock worth $293,236,000 after purchasing an additional 297,076 shares during the period. Finally, Assenagon Asset Management S.A. increased its stake in STERIS by 305.9% in the third quarter. Assenagon Asset Management S.A. now owns 330,907 shares of the medical equipment provider’s stock valued at $81,880,000 after purchasing an additional 249,386 shares in the last quarter. 94.69% of the stock is currently owned by institutional investors.

STERIS Stock Performance

NYSE STE opened at $255.68 on Thursday. The company has a fifty day moving average price of $253.68 and a 200-day moving average price of $244.40. The firm has a market cap of $25.09 billion, a price-to-earnings ratio of 36.74 and a beta of 1.01. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.37 and a quick ratio of 1.63. STERIS plc has a 1 year low of $200.98 and a 1 year high of $268.60.

STERIS (NYSE:STE) last released its quarterly earnings results on Wednesday, November 5th. The medical equipment provider reported $2.47 earnings per share for the quarter, topping the consensus estimate of $2.38 by $0.09. STERIS had a net margin of 12.07% and a return on equity of 14.43%. The business had revenue of $1.46 billion for the quarter, compared to analysts’ expectations of $1.43 billion. During the same period in the previous year, the company earned $2.14 earnings per share. STERIS has set its FY 2026 guidance at 10.150-10.30 EPS. As a group, equities research analysts predict that STERIS plc will post 9.08 EPS for the current fiscal year.

STERIS Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, December 18th. Shareholders of record on Tuesday, November 18th were given a $0.63 dividend. The ex-dividend date of this dividend was Tuesday, November 18th. This represents a $2.52 annualized dividend and a yield of 1.0%. STERIS’s payout ratio is currently 36.21%.

Insiders Place Their Bets

In other STERIS news, VP Renato Tamaro sold 5,036 shares of the company’s stock in a transaction on Tuesday, November 18th. The stock was sold at an average price of $257.55, for a total value of $1,297,021.80. Following the completion of the transaction, the vice president owned 5,695 shares in the company, valued at $1,466,747.25. This represents a 46.93% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, VP Julia Madsen sold 5,008 shares of the business’s stock in a transaction dated Friday, November 21st. The stock was sold at an average price of $262.00, for a total transaction of $1,312,096.00. Following the completion of the transaction, the vice president directly owned 10,710 shares in the company, valued at $2,806,020. This trade represents a 31.86% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 25,203 shares of company stock worth $6,624,667 over the last 90 days. Company insiders own 1.07% of the company’s stock.

Analysts Set New Price Targets

A number of analysts recently commented on STE shares. Weiss Ratings reaffirmed a “buy (b)” rating on shares of STERIS in a research report on Tuesday, October 14th. Wall Street Zen upgraded shares of STERIS from a “buy” rating to a “strong-buy” rating in a research note on Sunday, September 14th. Seven investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to MarketBeat.com, STERIS has a consensus rating of “Moderate Buy” and a consensus target price of $273.50.

About STERIS

STERIS Corporation (NYSE: STE) is a global provider of infection prevention, contamination control and procedural products and services for the healthcare, life sciences, pharmaceutical and medical device industries. The company develops, manufactures and supports a broad portfolio of equipment and consumables designed to reduce risk of infection, maintain sterile environments and support critical clinical and manufacturing procedures.

Its offerings include sterilization and decontamination systems, instrument washers and washers-disinfectors, endoscope reprocessing solutions, surgical equipment and procedural disposables, and contamination-control products for cleanrooms and laboratories.